Th17 cells expressing KIR3DL2 and enriched for gut homing markers are increased in ankylosing spondylitis

Th17 cells expressing KIR3DL2 and enriched for gut homing markers are increased in ankylosing spondylitis

Taispeáin leaganacha eile (2)

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Ridley, A, Kollnberger, S, Wong, I, Shaw, J, Chan, A, Fleming, M, Cummings, F, Bowness, P
Formáid:	Conference item
Foilsithe / Cruthaithe:	2011

Míreanna comhchosúla

TH17 CELLS EXPRESSING KIR3DL2 AND ENRICHED FOR GUT HOMING MARKERS ARE INCREASED IN ANKYLOSING SPONDYLITIS
de réir: Ridley, A, et al.
Foilsithe / Cruthaithe: (2012)

TH17 CELLS EXPRESSING KIR3DL2 AND ENRICHED FOR GUT HOMING MARKERS ARE INCREASED IN ANKYLOSING SPONDYLITIS
de réir: Ridley, A, et al.
Foilsithe / Cruthaithe: (2012)

Th17 cells expressing KIR3DL2+are increased in ankylosing spondylitis
de réir: Ridley, A, et al.
Foilsithe / Cruthaithe: (2010)

KIR3DL2 INTERACTION WITH HLA-B27 PROMOTES THE SURVIVAL OF TH17 CELLS IN ANKYLOSING SPONDYLITIS
de réir: Kollnberger, S, et al.
Foilsithe / Cruthaithe: (2010)

KIR3DL2 INTERACTION WITH HLA-B27 PROMOTES THE SURVIVAL OF TH17 CELLS IN ANKYLOSING SPONDYLITIS
de réir: Kollnberger, S, et al.
Foilsithe / Cruthaithe: (2010)

Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.
de réir: Bowness, P, et al.
Foilsithe / Cruthaithe: (2011)

Increased IL-23 Receptor Expression Is Observed On KIR3DL2+CD4+T Cells In Ankylosing Spondylitis and Correlates With IL-23R Polymorphisms
de réir: Ridley, A, et al.
Foilsithe / Cruthaithe: (2013)

Increased IL-23 receptor expression is observed on KIR3DL2+CD4+T cells in Ankylosing Spondylitis and correlates with IL-23R polymorphisms
de réir: Ridley, A, et al.
Foilsithe / Cruthaithe: (2013)

CHARACTERIZING TYPE 17 IMMUNE RESPONSES IN ANKYLOSING SPONDYLITIS
de réir: Al-Mossawi, H, et al.
Foilsithe / Cruthaithe: (2013)

No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis.
de réir: McCappin, J, et al.
Foilsithe / Cruthaithe: (2010)

TH17 T CELLS IN ANKYLOSING SPONDYLITIS ARE POLYFUNCTIONAL AND EXPRESS HIGH LEVELS OF THE CHEMOKINE RECEPTOR CCR6
de réir: Bowness, P, et al.
Foilsithe / Cruthaithe: (2009)

KIR3DL2 Binds to HLA-B27 Dimers and Free H Chains More Strongly than Other HLA Class I and Promotes the Expansion of T Cells in Ankylosing Spondylitis.
de réir: Wong-Baeza, I, et al.
Foilsithe / Cruthaithe: (2013)

KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis.
de réir: Wong-Baeza, I, et al.
Foilsithe / Cruthaithe: (2013)

THE ROLE OF HLA-B27 KIR3DL2 INTERACTIONS IN THE PATHOGENESIS OF SPONDYLOARTHRITIS
de réir: Kollnberger, S, et al.
Foilsithe / Cruthaithe: (2012)

Lack of association of KIR3DL1 or KIR3DS1 with ankylosing spondylitis in a UK population
de réir: Harvey, D, et al.
Foilsithe / Cruthaithe: (2007)

HLA-B27 and KIR3DL2 Interactions Promote The Differentiation and Survival Of Proinflammatory T Cells In Spondyloarthritis
de réir: Ridley, A, et al.
Foilsithe / Cruthaithe: (2013)

No association of alleles of the killer immunoglobulin-like receptor gene KIR3DL2 with ankylosing spondylitis
de réir: Harvey, D, et al.
Foilsithe / Cruthaithe: (2008)

No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis (vol 75, pg 68, 2009)
de réir: McCappin, J, et al.
Foilsithe / Cruthaithe: (2011)

Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis.
de réir: Chen, L, et al.
Foilsithe / Cruthaithe: (2015)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
de réir: Wong-Baeza, I, et al.
Foilsithe / Cruthaithe: (2011)

HLA-B27 homodimers differ in their interactions with LILRB1, LILRB2, KIR3DL1 and KIR3DL2 compared to HLA-B27 heterotrimers
de réir: Giles, J, et al.
Foilsithe / Cruthaithe: (2010)

Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases
de réir: Hammitzsch, A, et al.
Foilsithe / Cruthaithe: (2018)

HLA-B*2709, A SUBTYPE NOT ASSOCIATED WITH ANKYLOSING SPONDYLITIS, FORMS FEWER HOMODIMERS THAN HLA-B*2705
de réir: Giles, J, et al.
Foilsithe / Cruthaithe: (2010)

The immunology of Ankylosing Spondylitis
de réir: Bowness, P
Foilsithe / Cruthaithe: (2011)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
de réir: Kollnberger, S, et al.
Foilsithe / Cruthaithe: (2007)

Molecular determinants for KIR3DL2 binding to HLA-B27 and other HLA-class I ligands
de réir: Hatano, H, et al.
Foilsithe / Cruthaithe: (2013)

Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis.
de réir: Chan, A, et al.
Foilsithe / Cruthaithe: (2005)

miR-10b-5p is a novel Th17 regulator present in Th17 cells from Ankylosing Spondylitis
de réir: Chen, L, et al.
Foilsithe / Cruthaithe: (2017)

INVESTIGATING THE ROLE OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE-1 IN ANKYLOSING SPONDYLITIS
de réir: Chen, L, et al.
Foilsithe / Cruthaithe: (2012)

New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease.
de réir: Shaw, J, et al.
Foilsithe / Cruthaithe: (2012)

Expansion and increased survival of natural killer and CD4 T cells expressing the Killer IG-like Receptor KIR3DL2 in spondyloarthritis.
de réir: Chan, A, et al.
Foilsithe / Cruthaithe: (2005)

Enhanced Expression of KIR3DL2 in Natural Killer and CD3/CD4 Positive T Cells of Ankylosing Spondylitis Patients Compared to HLA-B*2705 or B*2709 Healthy Subjects
de réir: Cauli, A, et al.
Foilsithe / Cruthaithe: (2011)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
de réir: Bowness, P, et al.
Foilsithe / Cruthaithe: (2010)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
de réir: Bowness, P, et al.
Foilsithe / Cruthaithe: (2010)

OVERVIEW OF ANKYLOSING SPONDYLITIS GENETICS AND PATHOGENESIS
de réir: Bowness, P
Foilsithe / Cruthaithe: (2012)

New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease
de réir: Jacqueline eShaw, et al.
Foilsithe / Cruthaithe: (2012-11-01)

EXPRESSION OF HLA-B27 HEAVY CHAIN FORMS IN ANKYLOSING SPONDYLITIS AND HLA-B27 POSITIVE CELL LINES
de réir: Rysnik, O, et al.
Foilsithe / Cruthaithe: (2012)

Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705.
de réir: Stewart-Jones, G, et al.
Foilsithe / Cruthaithe: (2005)

EPIGENETIC REGULATION OF THE IL-23R LOCUS IN ANKYLOSING SPONDYLITIS
de réir: Cohen, C, et al.
Foilsithe / Cruthaithe: (2013)

INVESTIGATING THE ROLE OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE-1 (ERAP1) IN ANKYLOSING SPONDYLITIS
de réir: Chen, L, et al.
Foilsithe / Cruthaithe: (2010)